Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.

Clinical trial NCT03729258 · UNKNOWN

Trial details

NCT number: NCT03729258
Sponsor: Neutec Ar-Ge San ve Tic A.Ş
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Sinusitis Sinusitis, Acute Rhinosinusitis Rhinosinusitis Acute Sinus Infection

Start date: 2019-05-15
Primary completion: 2023-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.